Celldex Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -16.8% | -16.8% | -15.9% |
| FY2022 | -34.4% | -34.4% | -31.8% |
| FY2023 | -33.0% | -33.0% | -30.4% |
| FY2024 | -21.1% | -21.1% | -19.9% |
| FY2025 | -49.1% | -49.1% | -44.4% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -16.8% | -16.8% | -15.9% |
| FY2022 | -34.4% | -34.4% | -31.8% |
| FY2023 | -33.0% | -33.0% | -30.4% |
| FY2024 | -21.1% | -21.1% | -19.9% |
| FY2025 | -49.1% | -49.1% | -44.4% |